Novartis Tests New Alzheimer's Drugs on People Who Don't Have the Disease

Subjects at high risk of developing Alzheimer’s—but who don’t actually have the disease—are being recruited to help test two experimental treatments from Novartis AG, in a new focus on preventive treatment.

from WSJ.com: US Business http://ift.tt/2pohStF
via IFTTT